CLINICAL_TRIALS
trial_result
· 2020-03-30
Clinical Trial Update: Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis [Phase 2]
Summary
Phase 2 clinical trial evaluating bendamustine and dexamethasone in relapsed AL amyloidosis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: AL Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2020-03-30